PArtnership Opportunity

---

Ibadah International has successfully created a network of partners for our Thies agricultural project. We have acquired a total of 9 hectares (24 acres) of land in Senegal, West Africa. The value of our land acquisition is currently $400K and will accrue to over $4 million USD in the next 3-4 years. Our agricultural operation consists of cultivation, processing, extraction, purification, and sales. Our minimum expected annual revenue is between $4M to $6M.

We are an extraction processor of therapeutic plant bio-chemicals; an extraction company. This includes all parts of the plant including seed, foliage, flowers, stalk,  etc. Examples of our crops include flax, chili peppers, baobab, hibiscus, neem, saffron, nilotica, etc. Our farming enterprise cultivates plant products that we process for medicinal extraction, or further commercial and industrial uses. Our newly acquired land will allow us to expand into at least five new product plants each capable of $500K to $1M potential annual revenue.

Our current company valuation is $11.75M USD. We have completed all preliminary micro-partnership rounds and are in Phase III of our project business plan.  This phase is operational with some aspects of infrastructure ongoing and some operations commencing. A few of the key tasks include facility construction, irrigation, and energy systems. We are also prepping the land for cultivation.

We are offering 4.5% global company investment. The breakout of the offering is as follows. 

1% @ $37,500 once completed the valuation will change to the following:

1% @ $113,000 for a total of three and half positions (3.5%)

 Our agricultural operation consists of cultivation, processing, extraction, purification, and sale. Our minimum expected annual revenue is between $4M to $6M, with a profit margin of approx. 40%.  Your ROI for round one .15% can earn between $4k - $6,000 per year from this investment in the short term 1-3 years. That is $25,000 over the next 5 years and $50,000 over the next 10 years. While we can not say definitively that we will make more than our projections, we expect to exceed our calculations.